BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11316514)

  • 1. Pharmacologic therapy of persistent pulmonary hypertension of the newborn.
    Weinberger B; Weiss K; Heck DE; Laskin DL; Laskin JD
    Pharmacol Ther; 2001 Jan; 89(1):67-79. PubMed ID: 11316514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on PPHN: mechanisms and treatment.
    Nair J; Lakshminrusimha S
    Semin Perinatol; 2014 Mar; 38(2):78-91. PubMed ID: 24580763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn.
    Kinsella JP; Truog WE; Walsh WF; Goldberg RN; Bancalari E; Mayock DE; Redding GJ; deLemos RA; Sardesai S; McCurnin DC; Moreland SG; Cutter GR; Abman SH
    J Pediatr; 1997 Jul; 131(1 Pt 1):55-62. PubMed ID: 9255192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and Future Treatments for Persistent Pulmonary Hypertension in the Newborn.
    Pedersen J; Hedegaard ER; Simonsen U; Krüger M; Infanger M; Grimm D
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):392-406. PubMed ID: 29855164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPHN: is sildenafil the new nitric? A review of the literature.
    Spillers J
    Adv Neonatal Care; 2010 Apr; 10(2):69-74. PubMed ID: 20386371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.
    Kelly LK; Porta NF; Goodman DM; Carroll CL; Steinhorn RH
    J Pediatr; 2002 Dec; 141(6):830-2. PubMed ID: 12461501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilators in persistent pulmonary hypertension of the newborn: a need for optimal appraisal of efficacy.
    Gouyon JB; Françoise M
    Dev Pharmacol Ther; 1992; 19(2-3):62-8. PubMed ID: 1340438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
    Lakshminrusimha S; Mathew B; Leach CL
    Semin Perinatol; 2016 Apr; 40(3):160-73. PubMed ID: 26778236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future therapeutic options for persistent pulmonary hypertension in the newborn.
    Rao S; Bartle D; Patole S
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):845-62. PubMed ID: 20528642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure. French Paediatric Study Group of Inhaled NO.
    Mercier JC; Lacaze T; Storme L; Rozé JC; Dinh-Xuan AT; Dehan M
    Eur J Pediatr; 1998 Sep; 157(9):747-52. PubMed ID: 9776535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled nitric oxide in the treatment of persistent pulmonary hypertension/ hypoxic respiratory failure in neonates: an update.
    Cook LN; Stewart DL
    J Ky Med Assoc; 2005 Apr; 103(4):138-47. PubMed ID: 15853181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of MAS with PPHN using combined therapy: SLL, bolus surfactant and iNO.
    Gadzinowski J; Kowalska K; Vidyasagar D
    J Perinatol; 2008 Dec; 28 Suppl 3():S56-66. PubMed ID: 19057612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and management of pulmonary hypertension.
    Wanstall JC; Jeffery TK
    Drugs; 1998 Dec; 56(6):989-1007. PubMed ID: 9878988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Persistent Pulmonary Hypertension of the Newborn: Use of Pulmonary Vasodilators in Term Neonates.
    Luecke C; McPherson C
    Neonatal Netw; 2017 May; 36(3):160-168. PubMed ID: 28494828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn.
    Fineman JR; Zwass MS
    Acta Paediatr Jpn; 1995 Aug; 37(4):425-30. PubMed ID: 7572140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
    Lai MY; Chu SM; Lakshminrusimha S; Lin HC
    Pediatr Neonatol; 2018 Feb; 59(1):15-23. PubMed ID: 28923474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants. A feasibility study.
    Al Omar S; Salama H; Al Hail M; Al Rifai H; Bunahia M; El Kasem W; Siddiqui FJ; Dilawar M; Yassin H; Masud F; Mohamed A; Mansour A
    J Neonatal Perinatal Med; 2016 Sep; 9(3):251-9. PubMed ID: 27589542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic pyloric stenosis following persistent pulmonary hypertension of the newborn: a case report and literature review.
    Iijima S; Ueno D; Baba T; Ohishi A
    BMC Pediatr; 2018 Sep; 18(1):290. PubMed ID: 30176827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
    Ko SY; Chang YS; Park WS
    J Korean Med Sci; 1998 Oct; 13(5):500-6. PubMed ID: 9811179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide-treated with milrinone: a case report.
    Tzialla C; Cerbo RM; Perotti G; Stronati M
    Turk J Pediatr; 2010; 52(1):78-80. PubMed ID: 20402071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.